DK1051491T3 - Equin Fc Epsilon receptor-alfa-kæde-nukleinsyremolekyler, korresponderende proteiner og anvendelse heraf - Google Patents

Equin Fc Epsilon receptor-alfa-kæde-nukleinsyremolekyler, korresponderende proteiner og anvendelse heraf

Info

Publication number: DK1051491T3
Authority: DK; Denmark
Prior art keywords: nucleic acid; acid molecules; proteins; epsilon receptor; alpha chain
Prior art date: 1998-01-29

Application number

DK99905532.0T

Other languages

English (en)

Inventor

Eric R Weber

Catherine A Mccall

Original Assignee

Heska Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-01-29

Filing date

1999-01-28

Publication date

2010-08-16

1999-01-28 Application filed by Heska Corp filed Critical Heska Corp

2010-08-16 Application granted granted Critical

2010-08-16 Publication of DK1051491T3 publication Critical patent/DK1051491T3/da

Links

108090000623 proteins and genes Proteins 0.000 title abstract 6
102000004169 proteins and genes Human genes 0.000 title abstract 6
102000039446 nucleic acids Human genes 0.000 title abstract 4
108020004707 nucleic acids Proteins 0.000 title abstract 4
150000007523 nucleic acids Chemical class 0.000 title abstract 4
102000009438 IgE Receptors Human genes 0.000 title abstract 3
108010073816 IgE Receptors Proteins 0.000 title abstract 3
QTTMOCOWZLSYSV-QWAPEVOJSA-M equilin sodium sulfate Chemical compound [Na+].[O-]S(=O)(=O)OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4C3=CCC2=C1 QTTMOCOWZLSYSV-QWAPEVOJSA-M 0.000 title 1
239000000203 mixture Substances 0.000 abstract 2
230000001225 therapeutic effect Effects 0.000 abstract 2
241000283073 Equus caballus Species 0.000 abstract 1
230000008512 biological response Effects 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
239000003112 inhibitor Substances 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
230000001404 mediated effect Effects 0.000 abstract 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/24—Immunology or allergic disorders
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/862—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgE or IgD
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Organic Chemistry (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Medicinal Chemistry (AREA)
Cell Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Toxicology (AREA)
Analytical Chemistry (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Biophysics (AREA)
Microbiology (AREA)
Zoology (AREA)
Food Science & Technology (AREA)
Physics & Mathematics (AREA)
Gastroenterology & Hepatology (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK99905532.0T 1998-01-29 1999-01-28 Equin Fc Epsilon receptor-alfa-kæde-nukleinsyremolekyler, korresponderende proteiner og anvendelse heraf DK1051491T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US09/015,734 US6057127A (en)	1998-01-29	1998-01-29	Equine Fc epsilon receptor alpha chain nucleic acid molecules and uses thereof
PCT/US1999/001903 WO1999038974A1 (en)	1998-01-29	1999-01-28	EQUINE Fc EPSILON RECEPTOR ALPHA CHAIN NUCLEIC ACID MOLECULES, CORRESPONDING PROTEINS AND USES THEREOF

Publications (1)

Publication Number	Publication Date
DK1051491T3 true DK1051491T3 (da)	2010-08-16

Family

ID=21773286

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK99905532.0T DK1051491T3 (da)	1998-01-29	1999-01-28	Equin Fc Epsilon receptor-alfa-kæde-nukleinsyremolekyler, korresponderende proteiner og anvendelse heraf

Country Status (10)

Country	Link
US (5)	US6057127A (da)
EP (1)	EP1051491B1 (da)
AT (1)	ATE474047T1 (da)
AU (1)	AU746218B2 (da)
CA (1)	CA2319310C (da)
DE (1)	DE69942575D1 (da)
DK (1)	DK1051491T3 (da)
ES (1)	ES2348971T3 (da)
PT (1)	PT1051491E (da)
WO (1)	WO1999038974A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6057127A (en) *	1998-01-29	2000-05-02	Heska Corporation	Equine Fc epsilon receptor alpha chain nucleic acid molecules and uses thereof
AU7878900A (en)	1999-10-15	2001-04-30	Heska Corporation	Method for production and use of mite group 1 proteins
US6889145B1 (en)	2000-03-15	2005-05-03	Northwestern University	Three-dimensional model of a Fc region of an IgE antibody and uses thereof
AU2001273456A1 (en) *	2000-07-13	2002-01-30	Hyseq, Inc.	Soluble immunoglobulin e receptor alpha like molecules
US6916626B1 (en) *	2001-04-25	2005-07-12	Rockeby Biomed Ltd.	Detection of Candida
US6753303B2 (en) *	2001-12-06	2004-06-22	Hershey Entertainment & Resorts Company	Whipped cocoa bath
US20070122413A1 (en) *	2005-11-28	2007-05-31	Sivakumar Pallavur V	Il-21 antagonists
WO2008086413A2 (en) *	2007-01-09	2008-07-17	Mystic Pharmaceuticals, Inc.	Intranasal cartridge devices
EP2373579A2 (en) *	2008-12-08	2011-10-12	Tisol, Llc	Multicomponent nanoparticle materials and process and apparatus therefor
WO2017094027A1 (en) *	2015-12-01	2017-06-08	Cipla Limited	Nasal spray assembly
EP3192806A1 (en) *	2016-01-13	2017-07-19	Affiris AG	Alpha chain of the high-affinity ige receptor (fceria)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3956752A (en) *	1975-03-12	1976-05-11	Harris Corporation	Polarization insensitive lens formed of spiral radiators
US4962035A (en) *	1987-12-01	1990-10-09	President And Fellows Of Harvard College	DNA encoding IgE receptor alpha-subunit or fragment thereof
CA2000878C (en) *	1988-10-18	1999-06-29	Jean-Pierre Kinet	Cdnas coding for the subunit of the high-affinity receptor for immunoglobulin e
WO1991006570A1 (en) *	1989-10-25	1991-05-16	The University Of Melbourne	HYBRID Fc RECEPTOR MOLECULES
US5965709A (en) *	1991-08-14	1999-10-12	Genentech, Inc.	IgE antagonists
EP1260521B1 (en) *	1991-08-14	2007-11-21	Genentech Inc.	Immunoglobulin variants for specific Fc epsilon receptors
US5770396A (en) *	1992-04-16	1998-06-23	The United States Of America As Represented By The Department Of Health And Human Services	Isolation characterization, and use of the human beta subunit of the high affinity receptor for immunoglobulin E
FR2697485B1 (fr) *	1992-11-02	1995-01-20	Valeo Vision	Feu de signalisation à éléments lumineux modulaires, pour véhicule automobile.
US5945294A (en) *	1996-11-26	1999-08-31	Heska Corporation	Method to detect IgE
US5958880A (en) *	1996-12-19	1999-09-28	Heska Corporation	Feline Fc epsilon receptor alpha chain proteins and therapeutic uses thereof
US6057127A (en) *	1998-01-29	2000-05-02	Heska Corporation	Equine Fc epsilon receptor alpha chain nucleic acid molecules and uses thereof

1998
- 1998-01-29 US US09/015,734 patent/US6057127A/en not_active Expired - Lifetime
1999
- 1999-01-28 DK DK99905532.0T patent/DK1051491T3/da active
- 1999-01-28 DE DE69942575T patent/DE69942575D1/de not_active Expired - Lifetime
- 1999-01-28 ES ES99905532T patent/ES2348971T3/es not_active Expired - Lifetime
- 1999-01-28 WO PCT/US1999/001903 patent/WO1999038974A1/en not_active Ceased
- 1999-01-28 AU AU25674/99A patent/AU746218B2/en not_active Expired
- 1999-01-28 AT AT99905532T patent/ATE474047T1/de not_active IP Right Cessation
- 1999-01-28 PT PT99905532T patent/PT1051491E/pt unknown
- 1999-01-28 EP EP99905532A patent/EP1051491B1/en not_active Expired - Lifetime
- 1999-01-28 CA CA2319310A patent/CA2319310C/en not_active Expired - Lifetime
2000
- 2000-02-29 US US09/515,311 patent/US6582701B1/en not_active Expired - Lifetime
2003
- 2003-05-08 US US10/434,817 patent/US6887672B2/en not_active Expired - Lifetime
2005
- 2005-03-21 US US11/086,903 patent/US7226996B2/en not_active Expired - Fee Related
2007
- 2007-05-16 US US11/749,660 patent/US20070238196A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US6057127A (en)	2000-05-02
ES2348971T3 (es)	2010-12-17
AU2567499A (en)	1999-08-16
US20070238196A1 (en)	2007-10-11
CA2319310A1 (en)	1999-08-05
EP1051491B1 (en)	2010-07-14
US20030235579A1 (en)	2003-12-25
WO1999038974A1 (en)	1999-08-05
ATE474047T1 (de)	2010-07-15
DE69942575D1 (de)	2010-08-26
US6887672B2 (en)	2005-05-03
CA2319310C (en)	2011-05-24
EP1051491A1 (en)	2000-11-15
US7226996B2 (en)	2007-06-05
AU746218B2 (en)	2002-04-18
US20050170466A1 (en)	2005-08-04
US6582701B1 (en)	2003-06-24
PT1051491E (pt)	2010-08-20

Publication	Publication Date	Title
ATE398676T2 (de)	2008-07-15	Antagonistische selektive bindungsagenzien des osteoprotegerin-bindungsproteins
DK1053256T3 (da)	2011-10-03	Antistoffer mod Dødsreceptor 4 (DR4) og anvendelser deraf
NO985376L (no)	1998-11-19	Kinolinkarboksamider som TNF-inhibitorer og som PDA-IV inhibitorer
NO20043245L (no)	2004-10-04	Bindingsproteiner som biosensorer
BRPI0408247A (pt)	2006-03-01	usos de antagonistas e agonistas de il-23 e reagentes relacionados
DE602004014117D1 (de)	2008-07-10	Thiazole zur verwendung als inhibitoren von protein-kinasen
NO20082559L (no)	2008-07-07	Humane monoklonale antistoffer mot protein tyrosin kinase 7 (PTK7) og fremgangsmater for anvendelse av anti-PTK7 antistoffer
NO20043259L (no)	2004-09-16	Bindingsproteiner som biosensorer
NO20080362L (no)	2008-03-17	CD19-antistoffer og deres anvendelser
DK1005540T3 (da)	2004-10-18	IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
CY1113096T1 (el)	2016-04-13	Αντισωματα της ip-10 και οι χρησεις αυτων
DE602005023529D1 (de)	2010-10-21	Homogener nachweis von analyten
DE60314500D1 (de)	2007-08-02	Diaminopyrimidine und deren verwendung als angiogenesehemmer
EP1687283A4 (en)	2008-09-24	FOR THE DETERMINATION OF FK506 PROCEDURE AND COMPOSITION
NO20043257D0 (no)	2004-08-03	Innkapslede bindingsproteiner som biosensorer
NO20064866L (no)	2006-12-22	IRTA-5 antistoffer og deres anvendelse
ATE482936T1 (de)	2010-10-15	Als b-sekretase (bace)-hemmer nützliche 2-amino- chinazolinderivate
ATE417605T1 (de)	2009-01-15	Proteine die cross-beta-struktur enthaltendes amyloid binden, sowie verfahren zur modulation der cross-beta-struktur, ihrer bildung und der damit zusammenhängenden toxizität
EA200401453A1 (ru)	2005-06-30	Молекулы распознавания на клеточной поверхности, содержащие иммуноглобулиновый домен
FI20011664A7 (fi)	2003-02-18	Syöpäpesifiset oligoskkaridisekvenssit ja niiden käyttö
ATE474047T1 (de)	2010-07-15	Nukleinsäuremolekül, die für die alpha-kettedes pferde-fc-epsilon-rezeptors kodieren, korrespondierende proteine und ihre verwendungen
DE602005027399D1 (de)	2011-05-19	Für humane matriptase spezifische bindungsproteine
DE69732857D1 (de)	2005-04-28	Nukleinsaeuren und proteine der katze fc-epsilon rezeptor alpha-kette und deren verwendungen
MXPA05011085A (es)	2006-01-24	Composiciones y metodos relacionados a stop-1.
DK1465927T3 (da)	2011-04-18	BAG3-antistoffer til anvendelse til forskning, diagnostik og behandling af sygdomme, der omfatter celledød